The expanding demand for specific immunological research and therapeutic design has spurred significant improvements in recombinant cytokine generation. IL-1A, IL-1B, IL-2, and IL-3, each possessing unique functional roles, are frequently manufactured using multiple expression systems, including bacterial hosts, higher cell lines, and baculovirus t